BeOne Medicines (ONC) EBIT Margin Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1,536.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -170.00 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -3,724.00 |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 1,552.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,552.00 |
| Dec 31, 2025 | 1,939.00 |
| Sep 30, 2025 | 2,356.00 |
| Jun 30, 2025 | 1,821.00 |
| Mar 31, 2025 | 3,576.00 |
| Dec 31, 2024 | 5,345.00 |
| Sep 30, 2024 | 514.00 |
| Jun 30, 2024 | 4,201.00 |
| Mar 31, 2024 | 4,814.00 |
| Dec 31, 2023 | 6,279.00 |
| Sep 30, 2023 | 9,594.00 |
| Jun 30, 2023 | 7,510.00 |
| Mar 31, 2023 | 6,166.00 |
| Dec 31, 2022 | -21,235.00 |
| Sep 30, 2022 | 11,086.00 |
| Jun 30, 2022 | 18,794.00 |
| Mar 31, 2022 | -15,615.00 |
| Dec 31, 2021 | 57,348.00 |
| Sep 30, 2021 | 25,929.00 |
| Jun 30, 2021 | 23,020.00 |
| Mar 31, 2021 | 72,953.00 |
| Dec 31, 2020 | 19,763.00 |
| Sep 30, 2020 | 13,953.00 |
| Jun 30, 2020 | -48,955.00 |
| Mar 31, 2020 | -49,471.00 |
| Dec 31, 2019 | -20,344.00 |
| Sep 30, 2019 | -34,400.00 |
| Jun 30, 2019 | 25,156.00 |
| Mar 31, 2019 | 11,725.00 |
| Dec 31, 2018 | 9,251.00 |
| Sep 30, 2018 | -33,095.00 |
| Jun 30, 2016 | -579,094.00 |
| Mar 31, 2016 | -229,201.00 |